CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 11.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $483 | +108.2% | 53,393 | +145.6% | 0.00% | – |
Q2 2023 | $232 | -20.3% | 21,743 | -23.2% | 0.00% | – |
Q1 2023 | $291 | +28.2% | 28,313 | +31.7% | 0.00% | – |
Q4 2022 | $227 | -99.8% | 21,496 | +139.0% | 0.00% | – |
Q3 2022 | $116,000 | +24.7% | 8,994 | +23.8% | 0.00% | – |
Q2 2022 | $93,000 | +20.8% | 7,263 | -0.9% | 0.00% | – |
Q1 2022 | $77,000 | – | 7,328 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |